Journals / Eurasian Journal of Biological and Chemical Sciences / 2020 / Cilt: 3 - Sayı: 2

Evaluation of the morphological and ultrastructural effects of on liver tissues of scopolamine use in old rats

Yaşlı sıçanlarda skopolamin kullanımının karaciğer dokuları üzerine morfolojik ve ultrayapısal etkilerinin değerlendirilmesi

Pages
148–153
Publication Date
2020-12-29
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Scopolamine is metabolized by the liver, but is usually given in low doses (

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Evaluation of the morphological and ultrastructural effects of on liver tissues of scopolamine use in old rats Abstract: Scopolamine is a natural plant alkaloid with strong anticholinergic effects.
📊
Key Findings & Data:It competitively inhibits muscarinic receptors and produces both peripheral antimuscarinic effects and central sedative, antiemetic and amnesic effects.
💡
Conclusion & Impact:Scopolamine is metabolized by the liver, but is usually given in low doses (
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Karaciğer · Skopolamin · Liver

Abstract

Evaluation of the morphological and ultrastructural effects of on liver tissues of scopolamine use in old rats Abstract: Scopolamine is a natural plant alkaloid with strong anticholinergic effects. It competitively inhibits muscarinic receptors and produces both peripheral antimuscarinic effects and central sedative, antiemetic and amnesic effects. It has been used as an antiemetic, antisecretory and antispasmodic agent in the treatment of nausea, motion sickness, allergic rhinitis, duodenal ulcer disease, gastrointestinal discomfort and spasm, functional bowel syndrome and hyperactive bladder for many years. Scopolamine is metabolized by the liver, but is usually given in low doses (

Özet

Özet: Skopolamin güçlü antikolinerjik etkileri olan doğal bir bitki alkaloididir. Muskarinik reseptörleri rekabetçi bir şekilde inhibe eder ve hem periferik antimuskarinik etkiler, hem de merkezi sedatif, antiemetik ve amnezik etkiler üretir. Uzun yıllardır bulantı, hareket hastalığı, alerjik rinit, duodenal ülser hastalığı, gastrointestinal rahatsızlık ve spazm, fonksiyonel bağırsak sendromu ve hiperaktif mesane tedavisinde antiemetik, antisekretuar ve antispazmotik ajan olarak kullanılmaktadır. Skopolamin, karaciğer tarafından metabolize edilir, ancak genellikle sadece kısa süreler için düşük dozlarda (

🔖

Cite This Article

GÜRSU, B. Y., AKSÖZ, E., ASLAN, B., ÖZTÜRK, B. Y., DAĞ, İ. (2020). Evaluation of the morphological and ultrastructural effects of on liver tissues of scopolamine use in old rats. Eurasian Journal of Biological and Chemical Sciences, Cilt: 3 - Sayı: 2, 148–153. https://ajindex.com/articles/755984

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (8)

  1. Antor MA, Uribe AA, Erminy-Falcon N, Werner JG, Candiotti KA, Pergolizzi JV, Bergese SD 2014. The effect of transdermal scopolamine for the prevention of postoperative nausea and vomiting. Frontiers in pharmacology, 5: 55. Apfel CC, Zhang K, George E, Shi S, Jalota L, Hornuss C, Fero KE, et al. Transdermal scopolamine for the prevention of postoperative nausea and vomiting: a systematic review and meta-analysis. Clin Ther 2010; 32: 1987-2002.
  2. Auld DS, Kornecook TJ, Bastianetto S, Quirion R. Alzheimer's disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategies. Prog Neurobiol. 2002;68(3):209–245. doi:10.1016/s0301-0082(02)00079-5
  3. Bajo R, Pusil S, López ME, Canuet L, Pereda E, Osipova D, Maeustú F, Pekkonen E 2015. Scopolamine effects on functional brain connectivity: a pharmacological model of Alzheimer’s disease. Scientific reports, 5(1): 1-6.
  4. Chan TY, Tang CH, Critchley JA. Poisoning due to an over-the-counter hypnotic, Sleep-Qik (hyoscine, cyproheptadine, valerian). Postgrad Med J 1995; 71: 227-8.
  5. Chen C, Li XH, Zhang S, Tu Y, Wang YM, Sun HT 2014. 7, 8-dihydroxyflavone ameliorates scopolamine-induced Alzheimer-like pathologic dysfunction. Rejuvenation research, 17(3): 249-254.
  6. El-Marasy SA, Abd-Elsalam RM, Ahmed-Farid OA 2018. Ameliorative effect of silymarin on scopolamine-induced dementia in rats. Open access Macedonian journal of medical sciences, 6(7): 1215. Jeong EJ, Lee KY, Kim SH, Sung SH, Kim YC 2008. Cognitive-enhancing and antioxidant activities of iridoid glycosides from Scrophularia buergeriana in scopolamine-treated mice. European journal of pharmacology, 588(1): 78-84.
  7. Khosravi-Farsani N, Mashhadi Akbar Boojar M, Amini-Farsani Z, Heydari S, Teimori H 2016. Antioxidant and antiglycation effects of scopolamine in rat liver cells. Der Pharmacia Lettre, 8(1): 169-174.
  8. Klinkenberg I, Blokland A. The validity of scopolamine as a pharmacological model for cognitive impairment: a review of animal behavioral studies. Neurosci Biobehav Rev. 2010;34(8):1307–1350. doi:10.1016/j.neubiorev.2010.04.001 Kranke P, Morin AM, Roewer N, Wulf H, Eberhart LH. The efficacy and safety of transdermal scopolamine for the prevention of postoperative nausea and vomiting: a quantitative systematic review. Anesth Analg 2002; 95: 133-43. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet].Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012-